{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:21:39Z","timestamp":1784604099281,"version":"3.55.0"},"reference-count":18,"publisher":"Informa UK Limited","issue":"21","funder":[{"name":"Eisai"},{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bayer"},{"name":"Lilly"},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Roche"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.2217\/fon-2021-1255","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T08:37:52Z","timestamp":1653467872000},"page":"2635-2642","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Pregnancy and Perinatal Outcomes Following Exposure to Antineoplastic Agents Around Pregnancy within the US FDA Adverse Event Reporting System"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5117-2502","authenticated-orcid":false,"given":"Omar","family":"Abdel-Rahman","sequence":"first","affiliation":[{"name":"Department of Oncology,University of Alberta & Cross Cancer Institute,\rEdmonton,\rAB,\rT6G 1Z2,\rCanada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9763-5058","authenticated-orcid":false,"given":"Sunita","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Oncology,University of Alberta & Cross Cancer Institute,\rEdmonton,\rAB,\rT6G 1Z2,\rCanada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt199"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.10.014"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.2801"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e3181a44ca9"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70261-9"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.29.15_suppl.1099"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2009.11.007"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2009.11.004"},{"key":"e_1_3_3_11_1","unstructured":"US FDA . FDA Adverse Event Reporting System (FAERS) Public Dashboard (2021). www.fda.gov\/drugs\/questions-and-answers-fdas-adverse-event-reporting-system-faers\/fda-adverse-event-reporting-system-faers-public-dashboard"},{"key":"e_1_3_3_12_1","unstructured":"US FDA . Strengthening the reporting of observational studies in epidemiology (2022). www.strobe-statement.org\/"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22081"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds170"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666200916144249"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.13180"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08162-3"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/1933719110379650"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)71014-2"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e3181a44ca9"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2021-1255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T17:20:57Z","timestamp":1719422457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2021-1255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":18,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.2217\/fon-2021-1255"],"URL":"https:\/\/doi.org\/10.2217\/fon-2021-1255","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-10-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}